NCT04596826View on ClinicalTrials.gov

The Effect of Dronabinol on Ocular Hemodynamics in Patients With Primary Open Angle Glaucoma

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

November 11, 2020

Primary Completion Date

October 2, 2024

Study Completion Date

October 2, 2024

Conditions
Retinal Blood Flow
Interventions
DRUG

Dronabinol 5 MG

oral administration

DRUG

Dronabinol 10 MG

oral administration

DRUG

Placebo

oral administration

Trial Locations (1)

1090

Department of Clinical Pharmacology, Medical University Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT04596826 - The Effect of Dronabinol on Ocular Hemodynamics in Patients With Primary Open Angle Glaucoma | Biotech Hunter | Biotech Hunter